Building Investor Confidence in Microbiome Drug Development; how to Promote And Restore Confidence

Time: 4:45 pm
day: Day 2 - Track A Evening


  • Numerous challenges from bench to bedside but overall industry progress
  • Selecting therapeutically-relevant indications beyond C. difficile
  • The impact of recent clinical setbacks – Lessons learned on how and when to enter clinic with microbiome therapeutics